Ledger.Open graph →

SEC Form D · filed November 13, 2025

ELIXIRGEN THERAPEUTICS, INC

Offering

$4.0M

Sold

$4.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BALTIMORE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jeffrey Cleland · BALTIMORE, MDDirector Akihiro Ko · BALTIMORE, MDExec · Director Shauna Callahan · BALTIMORE, MDDirector Minoru Ko · BALTIMORE, MDDirector Hiroaki Kobayashi · BALTIMORE, MDDirector Thomas White · BALTIMORE, MDDirector Thomas White · BALTIMORE, MDDirector Akihiro Ko · BALTIMORE, MDExec · Director Jeffrey Cleland · BALTIMORE, MDDirector Hiroaki Kobayashi · BALTIMORE, MDDirector Shauna Callahan · BALTIMORE, MDDirector Minoru Ko · BALTIMORE, MDDirector Osvaldo Canavosio · WEST PALM BEACH, FLDirector Andrew Laurino · New York, NYDirector Jamie Lurie · New York, NYExec · Director James Roche · New York, NYDirector Justin Lee · New York, NYDirector Jane Siebels · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗